Cristina Rodriguez-Antona

Dr. Cristina Rodriguez-Antona

Spanish National Cancer Research Centre (CNIO)

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2007 in Pharmacology & Therapeutics
Verified
Journal Article
Closed access
MIMagnus Ingelman-Sundberg
Magnus Ingelman-Sundberg
SSSarah C. Sim
Sarah C. Sim
AGAlvin Gomez
Alvin Gomez
Cristina Rodriguez-AntonaCristina Rodriguez-Antona
Cristina Rodriguez-Antona

27 March 2017 in Nature Genetics
Verified
Journal Article
Open access
PDF file
CPCatherine M Phelan
Catherine M Phelan
KKKaroline B Kuchenbaecker
Karoline B Kuchenbaecker
JTJonathan P Tyrer
Jonathan P Tyrer
SKSiddhartha P. Kar
Siddhartha P. Kar
KLKate Lawrenson
Kate Lawrenson
PPPaul Pharoah
Paul Pharoah
Paul Pharoah and colleagues report the results of a large genome-wide association study of ovarian cancer. They identify new susceptibility loci for different epithelial ovarian cancer histotypes and use integrated analyses of genes and regulatory features at each locus to predict candidate susceptibility genes, including OBFC1. To identify common alleles associated with different histotypes of epithelial ovarian cancer (EOC), we pooled data from multiple genome-wide genotyping projects totaling 25,509 EOC cases and 40,941 controls. We identified nine new susceptibility loci for different EOC histotypes: six for serous EOC histotypes (3q28, 4q32.3, 8q21.11, 10q24.33, 18q11.2 and 22q12.1), two for mucinous EOC (3q22.3 and 9q31.1) and one for endometrioid EOC (5q12.3). We then performed meta-analysis on the results for high-grade serous ovarian cancer with the results from analysis of 31,448 BRCA1 and BRCA2 mutation carriers, including 3,887 mutation carriers with EOC. This identified three additional susceptibility loci at 2q13, 8q24.1 and 12q24.31. Integrated analyses of genes and regulatory biofeatures at each locus predicted candidate susceptibility genes, including OBFC1, a new candidate susceptibility gene for low-grade and borderline serous EOC.

13 March 2006 in Oncogene
Verified
Journal Article
Closed access
Cristina Rodriguez-AntonaCristina Rodriguez-Antona
Cristina Rodriguez-Antona
MIMagnus Ingelman-Sundberg
Magnus Ingelman-Sundberg

19 June 2011 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
ICIñaki Comino-Mendez
Iñaki Comino-Mendez
FGFrancisco J Gracia-Aznárez
Francisco J Gracia-Aznárez
Francesca SchiaviFrancesca Schiavi
Francesca Schiavi
Iñigo LandaIñigo Landa
Iñigo Landa
LLLuis J Leandro-García
Luis J Leandro-García
Alberto CasconAlberto Cascon
Alberto Cascon

1 January 2002 in Xenobiotica
Verified
Journal Article
Closed access
Cristina Rodriguez-AntonaCristina Rodriguez-Antona
Cristina Rodriguez-Antona
MDM. Teresa Donato
M. Teresa Donato
ABA. Boobis
A. Boobis
RER. J. Edwards
R. J. Edwards
PWP. S. Watts
P. S. Watts
MGM.-J. Gómez-Lechón
M.-J. Gómez-Lechón
1. Cultured hepatic cells have reduced cytochrome P450 (CYP) activities in comparison with human liver, but the mechanism(s) that underlies this circumstance is not clear. We investigated the causes of this low CYP activity by analysing the activity, protein, mRNA and heterologous nuclear RNA contents of the most important CYPs involved in drug metabolism (1A1, 1A2, 2A6, 2B6, 2C9, 2C19, 2D6, 2E1, 3A4, 3A5) in cultured human hepatocytes, and in HepG2 and Mz-Hep-1 hepatoma cell lines. 2. After 24 h of culture, hepatocytes retained most of their CYP activities and protein contents, but the mRNA decreased 20-fold. However, the mRNA content of most CYPs in 24-h hepatocytes was still 400-fold higher than in hepatoma cells. When we examined the transcriptional activity of the CYP genes, this decreased during culture time in hepatocytes and it was poor in hepatoma cell lines. 3. We investigated the abundance of key hepatic transcription factors that govern CYP transcription (C/EBP- β : LAP and LIP, HNF-3 α, HNF-4 α, RXR- α) and observed that the expression of some factors was altered in the hepatoma cells. 4. In conclusion, the loss of biotransformation activity in cultured hepatic cells is caused by a decrease in CYP transcription, which correlates with an alteration in the expression of key transcription factors.

26 February 2010 in Cytoskeleton
Verified
Journal Article
Closed access
PDF file
LLLuis J. Leandro‐García
Luis J. Leandro‐García
SLSusanna Leskelä
Susanna Leskelä
Iñigo LandaIñigo Landa
Iñigo Landa
CMCristina Montero-Conde
Cristina Montero-Conde
Elena López-JiménezElena López-Jiménez
Elena López-Jiménez
Cristina Rodriguez-AntonaCristina Rodriguez-Antona
Cristina Rodriguez-Antona